![Ankit Kedarmal Bankda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Net worth: 7 M $ as of 2026-06-29
Ankit Kedarmal Bankda has been associated with Syncom Formulations (India) Ltd. since 2014 and currently holds the position of Chairman, which started in 2025.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-12-30 | 46,886,420 ( 4.99% ) | 7 M $ | 2026-06-29 |
| Companies | Position | Start |
|---|---|---|
| SYNCOM FORMULATIONS (INDIA) LIMITED | Chairman | 2025-08-08 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 1 |
|---|---|
Syncom Formulations (India) Ltd.
 Syncom Formulations (India) Ltd. Pharmaceuticals: MajorHealth Technology Operates as a global pharmaceutical company, which discovers, develops, manufactures and markets healthcare products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
